![Bob B. Lamkin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Bob B. Lamkin
Entité | Type d'entité | Industrie | |
---|---|---|---|
TVM Capital Corp.
![]() TVM Capital Corp. Investment ManagersFinance TVM Capital Corp (TVM Capital) is a venture capital subsidary of TVM Capital GmbH founded in 1986. The firm is headquartered in Boston, Massachusetts.
14
| Subsidiary | Investment Managers | 14 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Bob B. Lamkin via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Venrock Associates
![]() Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Investment Managers | Private Equity Analyst | |
VPIsystems, Inc.
![]() VPIsystems, Inc. Packaged SoftwareTechnology Services VPIsystems, Inc. engages in the provision of network planning software and services for the global telecommunications industry. It enables optimized solutions through LTE network analytics for the escalating bandwidth requirements in backhaul and core networks. The company was founded in 1997 and is headquartered in Somerset, NJ. | Packaged Software | Director/Board Member | |
CONCERT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
RAPID MICRO BIOSYSTEMS, INC. | Industrial Machinery | Director/Board Member | |
Anchor Therapeutics, Inc.
![]() Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Anchor Therapeutics, Inc. designs and develops peptide modulators of G protein-coupled receptors (GPCRs). The firm engages in developing and licensing pepducin technology as a research tool for drug development; and pepducin drug candidates and novel molecules that are intended for targeting GPCR to allosterically modulate GPCR signaling. Its pepducin lipopeptides are designed to allosterically modulate internal cell signaling via specific interactions with intracellular GPCR domains. The company also focuses on developing its pepducin technology for creating new treatment options for regenerative medicine, diabetes, inflammation, and cancer. Anchor Therapeutics was founded by Thomas J. McMurry and Athan Kuliopulos in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Brown University | College/University | Doctorate Degree | |
GSK Equity Investments Ltd.
![]() GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | President | |
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
Stonesoft Oy
![]() Stonesoft Oy Packaged SoftwareTechnology Services Stonesoft Oy is engaged in the provision of integrated network security solutions. The firm offers security and protection of digital assets against cyber threats to private and public sector organizations. Its products include standalone firewalls, intrusion prevention systems, and virtual private network solutions. The company was founded by Ilka Hiidenheimo in 1990 and is headquartered in Helsinki, Finland. | Packaged Software | Corporate Officer/Principal | |
IMUGENE LIMITED | Biotechnology | Director/Board Member | |
Leerink Partners LLC
![]() Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Investment Banks/Brokers | Corporate Officer/Principal | |
Passport Capital LLC
![]() Passport Capital LLC Investment ManagersFinance Passport Capital LLC (Passport) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 2000 by John H. Burbank III. Passport serves as the investment manager to privately offered pooled investment vehicles. | Investment Managers | Portfolio Manager-Equities | |
GPC Biotech, Inc.
![]() GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Drugstore Chains | Corporate Officer/Principal | |
Bentley University | College/University | Masters Business Admin | |
Syracuse University | College/University | Undergraduate Degree | |
The University of Texas at Austin | College/University | Doctorate Degree | |
Pfizer Venture Investments LLC
![]() Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments LLC (Pfizer Ventures Investments) is a venture capital subsidiary of Pfizer Inc. founded in 2001. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
TransForm Pharmaceuticals, Inc.
![]() TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ENANTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SelectX Pharmaceuticals, Inc.
![]() SelectX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SelectX Pharmaceuticals, Inc. engages in the discovery and development of aminoglycoside therapeutics for unmet medical needs. Its advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistant gram-negative hospital-acquired infections (HAIs); SXP2523 possesses broad spectrum coverage with potency against Pseudomonas, Klebsiella, Acinetobacter, E. coli, and Staphylococcus. The company was founded by Michael G. Chaparian and Charles R. Cantor in 2002 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
WEIFA ASA | Pharmaceuticals: Major | Director/Board Member | |
The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree | |
Universität Konstanz | College/University | Doctorate Degree | |
Neomed Management (Jersey) Ltd.
![]() Neomed Management (Jersey) Ltd. Investment ManagersFinance Neomed Management (Jersey) Ltd. is an investment firm invests in innovative healthcare and life science companies. The company is headquartered in St. Helier, the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
EFECTE OY | Packaged Software | President | |
Pricewaterhousecoopers LLC | Corporate Officer/Principal | ||
Biohealth Innovation, Inc.
![]() Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Financial Conglomerates | Director/Board Member | |
Action Potential Venture Capital
![]() Action Potential Venture Capital Investment ManagersFinance Action Potential Venture Capital (Action Potential Venture) is a venture capital subsidiary of GlaxoSmithKline Plc founded in 2013. The firm is headquartered in London, United Kingdom. | Investment Managers | Director/Board Member | |
ZappRx, Inc.
![]() ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services ZappRx, Inc. develops prescription and prior authorization platform services. It provides healthcare providers, specialty pharmacies, biopharmacies, and security standards solutions. The company was founded by Zoe Barry in 2012 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Gladius Pharmaceuticals Corp.
![]() Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Gladius Pharmaceuticals Corp. operates as a biotechnology firm. The company is headquartered in Wilmington, DE. | Biotechnology | Director/Board Member | |
DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
IMD College | College/University | Masters Business Admin | |
Apollo Ventures Holding GmbH
![]() Apollo Ventures Holding GmbH Investment ManagersFinance Apollo Ventures Holding GmbH (Apollo Health Ventures) is an Independent Venture Capital firm founded in 2016 by Nils Regge and Alexandra Bause. The firm is headquartered in Hamburg. | Investment Managers | Private Equity Investor | |
Palleon Pharma, Inc.
![]() Palleon Pharma, Inc. BiotechnologyHealth Technology Palleon Pharma, Inc. operates as a biotechnology company. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Aeovian Pharmaceuticals, Inc.
![]() Aeovian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aeovian Pharmaceuticals, Inc. engages in the development of pharmaceuticals. It offers inhibitors for the treatment of rare and age-related diseases. The company was founded by Stelios T. Tzannis in 2012 and is headquartered in Novato, CA. | Pharmaceuticals: Major | Director/Board Member | |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Samsara Therapeutics, Inc.
![]() Samsara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Samsara Therapeutics, Inc. operates as a biopharmaceutical platform company. It engages in the development and commercialization of first-in-class therapeutics for the treatment of unmet medical needs and age-related diseases. The company was founded by Sebastian Aguiar in 2018 and is headquartered in Lewes, DE. | Pharmaceuticals: Major | Chief Executive Officer | |
Cleara Biotech BV
![]() Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Cleara Biotech BV operates as a biopharmaceutical company. It specializes in identification and specific elimination of subtypes of senescent cells with targeting age related diseases and counteracting therapy resistance in late stage cancer. The company was founded by Peter de Keizer, Marco Demaria, Tobias Madl and is headquartered in Utrecht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Aalto University School of Science & Technology | College/University | Undergraduate Degree | |
F-SECURE OYJ | Packaged Software | Corporate Officer/Principal | |
Vendep Capital Oy
![]() Vendep Capital Oy Investment ManagersFinance Vendep Capital Oy (Vendep) is a venture capital firm founded in 2002 by Hannu Kytölä. The firm is headquartered in Espoo, Finland. | Investment Managers | Private Equity Investor |
Statistiques
Internationale
Etats-Unis | 35 |
Finlande | 6 |
Allemagne | 5 |
Australie | 2 |
Norvège | 2 |
Sectorielle
Health Technology | 18 |
Finance | 11 |
Consumer Services | 11 |
Technology Services | 6 |
Commercial Services | 3 |
Opérationnelle
Director/Board Member | 51 |
Corporate Officer/Principal | 20 |
Private Equity Investor | 13 |
Undergraduate Degree | 8 |
Doctorate Degree | 8 |
Relations les plus connectées
- Bourse
- Insiders
- Bob B. Lamkin
- Connexions Sociétés